Sanjiv Patel insider trades

Open-market stock purchases and sales by Sanjiv Patel, President and CEO at Relay Therapeutics, Inc, from SEC Form 4 filings since Jul 20, 2020.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -8%.

Recent trades

DateStockTradeValue
Oct 7, 2026RLAY Relay Therapeutics, IncSold$872K
Sep 8, 2026RLAY Relay Therapeutics, IncSold$913K
Aug 17, 2026RLAY Relay Therapeutics, IncSold$980K
Jul 7, 2026RLAY Relay Therapeutics, IncSold$944K
Jun 30, 2026RLAY Relay Therapeutics, IncBought (not open market)$21.2K
Jan 13, 2026RLAY Relay Therapeutics, IncBought (not open market)—
Jan 6, 2026RLAY Relay Therapeutics, IncSold$338K
Dec 31, 2025RLAY Relay Therapeutics, IncBought (not open market)$3K
Nov 3, 2025RLAY Relay Therapeutics, IncSold$435K

Companies traded

  • RLAY Relay Therapeutics, Inc: 1 buy, 36 sales, last Oct 7, 2026
  • PRTA Prothena Corp Public Ltd Co: other filings, last May 18, 2022

Get free alerts when Sanjiv Patel files a new trade →